Neurocrine Biosciences Inc. (NBIX)
NASDAQ · Healthcare
Neurocrine Biosciences Inc. Operating Income 2009–2025
Neurocrine Biosciences Inc. annual/quarterly operating income history and growth rate from 2009 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Neurocrine Biosciences Inc. operating income for the quarter ending March 31, 2026 was 193.4 M, a 719.49% increase year-over-year.
- Neurocrine Biosciences Inc. operating income for the twelve months ending March 31, 2026 was 601.6 M, a 5.60% increase year-over-year.
- Neurocrine Biosciences Inc. annual operating income for 2025 was 619.1 M, a 8.52% increase from 2024.
- Neurocrine Biosciences Inc. annual operating income for 2024 was 570.5 M, a 127.38% increase from 2023.
- Neurocrine Biosciences Inc. annual operating income for 2023 was 250.9 M, a 0.76% increase from 2022.
- Neurocrine Biosciences Inc. annual operating income for 2022 was 249.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Neurocrine Biosciences Inc. Operating Income — FAQ
Neurocrine Biosciences Inc. (NBIX) operating income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Neurocrine Biosciences Inc.'s operating income?
Neurocrine Biosciences Inc. (NBIX) reported operating income of $619M for fiscal 2025.
Where can I see NBIX's operating income history?
The chart and table above show Neurocrine Biosciences Inc.'s operating income by year and by quarter, including the growth rate.